1. Home
  2. ICCC vs ANTA Comparison

ICCC vs ANTA Comparison

Compare ICCC & ANTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

N/A

Current Price

$9.91

Market Cap

93.1M

Sector

Health Care

ML Signal

N/A

Logo Antalpha Platform Holding Company Ordinary Shares

ANTA

Antalpha Platform Holding Company Ordinary Shares

N/A

Current Price

$3.53

Market Cap

96.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ICCC
ANTA
Founded
1982
2022
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
93.1M
96.5M
IPO Year
1995
2024

Fundamental Metrics

Financial Performance
Metric
ICCC
ANTA
Price
$9.91
$3.53
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$16.17
AVG Volume (30 Days)
27.5K
6.3K
Earning Date
05-15-2026
06-16-2026
Dividend Yield
N/A
N/A
EPS Growth
53.85
N/A
EPS
0.41
N/A
Revenue
$26,493,169.00
N/A
Revenue This Year
N/A
$21.95
Revenue Next Year
N/A
$30.46
P/E Ratio
$24.44
$19.77
Revenue Growth
51.64
N/A
52 Week Low
$4.52
$3.00
52 Week High
$12.10
$13.82

Technical Indicators

Market Signals
Indicator
ICCC
ANTA
Relative Strength Index (RSI) 42.02 48.29
Support Level $9.36 $3.00
Resistance Level $10.75 $4.17
Average True Range (ATR) 0.45 0.29
MACD -0.07 0.08
Stochastic Oscillator 29.56 62.69

Price Performance

Historical Comparison
ICCC
ANTA

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

About ANTA Antalpha Platform Holding Company Ordinary Shares

Antalpha Platform Holding Co provides financing, technology and risk management solutions to institutional and corporate customers in the crypto asset industry. The company operates through Antalpha Prime platform in the following areas: Supply chain financing and Technology and services. Its revenue prominently consists of technology financing fees charged on the supply chain loans.

Share on Social Networks: